NDC properties for NDC 9 49502-418
NDC item 49502041802
NDC 9 | 49502-418 |
---|---|
NDC 10 | 49502-418-02 |
NDC Item | 49502041802 |
packaging | 2 TRAY in 1 KIT (49502-418-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-482-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-483-06) / 1 mL in 1 PACKET |
BLA | BLA761154 |
FDA SPL set id | 860490 |
Labeler | Viatris Specialty LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time high | 2025-09-30 |
Marketing effective time low | 2023-07-02 |
Marketing status | ACTIVE |
NDC item 49502041806
NDC 9 | 49502-418 |
---|---|
NDC 10 | 49502-418-06 |
NDC Item | 49502041806 |
BLA | BLA761154 |
FDA SPL set id | 860490 |
Labeler | Viatris Specialty LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time high | 2025-09-30 |
Marketing effective time low | 2023-07-02 |
Marketing status | ACTIVE |
NDC item 51407083502
NDC 9 | 51407-835 |
---|---|
NDC 10 | 51407-835-02 |
NDC Item | 51407083502 |
packaging | 2 TRAY in 1 KIT (51407-835-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-846-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-847-02) / 1 mL in 1 PACKET |
BLA | BLA761154 |
FDA SPL set id | 847534 |
Labeler | Golden State Medical Supply Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2020-07-06 |
Marketing status | ACTIVE |
NDC item 51407084602
NDC 9 | 51407-846 |
---|---|
NDC 10 | 51407-846-02 |
NDC Item | 51407084602 |
packaging | 1 in 1 TRAY |
packaging | 2 in 1 KIT |
FDA SPL set id | 847534 |
Labeler | Golden State Medical Supply Inc. |
Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 83257002142
NDC 9 | 83257-021 |
---|---|
NDC 10 | 83257-021-42 |
NDC Item | 83257002142 |
packaging | 2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
BLA | BLA761154 |
FDA SPL set id | 788036 |
Labeler | Biocon Biologics Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-15 |
Marketing status | ACTIVE |